Latest AI and machine learning research in oncology/hematology for healthcare professionals.
INTRODUCTION: Lung cancer is the leading cause of cancer-related deaths worldwide, emphasizing the need for early and accurate diagnosis. Precise segmentation of lung regions and tumors in imaging is critical for effective diagnosis and treatment. This study investigates the Attention U-Net (Att-U-Net) model for segmenting lung tissues and tumors in positron emission tomography-computed tomography...
Breast cancer's (BC) diverse nature and global impact demand tailored clinical strategies. Conventional screening methods often fall short in early detection and individualized risk assessment. By merging multi-omics technologies such as genomics, transcriptomics, proteomics, and metabolomics with artificial intelligence (AI), clinicians gain powerful tools to navigate this complexity. AI's abilit...
Wildfire smoke exposures are increasingly common, consisting of complex mixtures of gases and particulates known to cause diverse pulmonary health eff...
BACKGROUND/AIMS: Intrahepatic cholangiocarcinoma (iCCA) represents an unmet clinical need due to its increasing incidence, aggressive biology, and lim...
Transendothelial migration (TEM), is a complex, multistep process impacted by diseases like autoimmune disorders and cancer. Deciphering aspects of th...
The differentiation between pathological subtypes of non-small cell lung cancer (NSCLC) is an essential step in guiding treatment options and prognosi...
Pathological examination stands as the cornerstone in cancer diagnosis, impacting millions worldwide annually. With the shortage of pathologists globa...
RATIONALE AND OBJECTIVE: The status of cervical lymph node metastasis(LNM) in Papillary thyroid carcinoma(PTC) can affect the patient's treatment plan...
BACKGROUND: We implemented a prospective screening program to detect deep venous thromboembolism and define its prevalence in patients with esophageal...
BACKGROUND AND OBJECTIVE: Differentiating T1-stage nasopharyngeal carcinoma (NPC) from benign hyperplasia (BH) is challenging. This study aims to cons...
Predicting pathological complete response (pCR) to neoadjuvant therapy (NAT) in breast cancer remains challenging due to high tumor heterogeneity and ...
Malignant stroke is a life-threatening condition, with mortality rates reaching up to 80% among patients managed conservatively. Brain swelling volume...
Circulating cell-free DNA (cfDNA) has emerged as a valuable non-invasive biomarker that provides unique insights into the spatial and temporal heterog...
Endocrine therapy remains one of the primary treatment modalities for estrogen receptor (ER) positive breast cancer, serving a pivotal role in improvi...
BACKGROUND: Microscopic, immunologic, and chemical testing play a major role in the diagnostic process of hematologic cancer patients. Pathologists re...
Lung cancer (LC) is one of the leading causes of death globally. Early detection is essential for saving lives and ensuring effective treatment for pa...
INTRODUCTION: Melanoma and Breast cancer are the leading cancers that cause thousands of deaths annually worldwide. Although several early identificat...
BACKGROUND: Predicting response to immune checkpoint inhibitor plus tyrosine kinase inhibitor (IO+TKI) therapy in metastatic renal cell carcinoma (mRC...
Metabolic dysfunction-associated steatohepatitis (MASH) represents a growing global health challenge due to its propensity to progress to irreversible...